News

20 Jun 2023

2023-06-20 16:16

Drug development faces several challenges in the current landscape,…

…and 3D organoids offer potential solutions to some of these challenges. Here are a few key challenges and how 3D organoids can help address them.

2023-06-20 16:16

11 Apr 2023

2023-04-11 13:15

At myriamed we have a lot of work to do in the lab. Why?

Because the myriamed services and 3D Organoids are well known for a better and faster drug development. Let´s talk about the facts…

2023-04-11 13:15

01 Dec 2022

2022-12-01 10:41

Animal Welfare Research Award: Alternative methods instead of animal cruelty

Parliamentary State Secretary Dr. Nick awards 41st Animal Welfare Research Prize – this year's award goes to scientists from Hannover and Göttingen.

2022-12-01 10:41

19 Sep 2022

2022-09-19 10:49

Myriamed at the Safety Pharmacology Society (SPS) Exhibition in Montreal

The Safety Pharmacology Society Annual meeting was held in Montréal, Canada from September 11 – 14, 2022. The myriamed team was on site with Dr. Eriona Heta, PhD and Dr. Tim Meyer.

2022-09-19 10:49

07 Jul 2022

2022-07-07 12:21

Myrtil Biotechnologies – innovating drug discovery for patients with dilated cardiomyopathy

The association Ksilink and myriamed GmbH founded Myrtil Biotechnologies, a company with its seat in Strasbourg, France, developing next generation therapeutics to treat dilated cardiomyopathy.

2022-07-07 12:21

11 Oct 2021

2021-10-11 11:23

myriamed launches online shop

To deliver the best possible service to our customers, myriamed has launched its own online shop. The shop features various human iPSC derived cell types (myrCell) such as cardiomyocytes, skeletal muscle cells and stroma cells as well as various tissue types (myrTissue) such as cardiac tissue, fibrotic tissue or brain organoids.

2021-10-11 11:23

28 Sep 2021

2021-09-28 15:46

myriamed is a member of the international 4D Bioprinting network

myriamed has become a member of the ZIM innovation network 4D Bioprinting. The network, which is led by EurA AG supports concrete innovative products and new services in the field of bioprinting for applications in biology, pharmacy, and medicine.

2021-09-28 15:46

19 Mar 2021

2021-03-19 10:08

myriamed has joined Science Exchange

Science Exchange, the leading SaaS-enabled marketplace platform for outsourced R&D services, has partnered with myriamed. Visit myriamed’s profile to inquire about our services or request a quote.

2021-03-19 10:08

06 Jan 2021

2021-01-06 15:43

myriamed is now a member of the Network for Pharma Solutions

We are proud to announce that myriamed is now a member of the Network for Pharma Solutions (NetPhaSol). NetPhaSol is a cooperation network focusing on drug discovery & development.